Summary & Overview
HCPCS L8030: Breast Prosthesis, Silicone, Without Integral Adhesive
HCPCS Level II code L8030 denotes a silicone (or equivalent) external breast prosthesis without integral adhesive, used to restore breast contour following mastectomy or other breast tissue loss. Nationally, this code matters because it represents a common durable medical equipment supply tied to post-mastectomy care, reconstruction alternatives, and coverage determinations across commercial and public payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage patterns, typical sites of service, and clinical context for dispensing and fitting of external breast prostheses. The publication highlights standard billing considerations, common modifiers used with HCPCS supplies, and where payers commonly align or differ on coverage criteria.
This report provides benchmarks for utilization and reimbursement where available, summarizes relevant policy language and prior authorization trends affecting access to prosthetic supplies, and situates L8030 within post-mastectomy care pathways. The content is intended for billing managers, prosthetics suppliers, clinical administrators, and policy analysts seeking a national perspective on coding and coverage for external breast prostheses without adhesive.
Billing Code Overview
HCPCS Level II code L8030 describes a breast prosthesis, silicone or equal, without integral adhesive. The service involves provision of an external breast prosthetic device designed to replace breast volume following mastectomy or other breast surgery. The typical service type is prosthetic supply/fitting, and the most common site of service is outpatient durable medical equipment supply, specialty prosthetics clinics, or surgical follow-up clinics.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a woman who has undergone unilateral or bilateral mastectomy for breast cancer or risk-reducing mastectomy and presents for outpatient fitting and provision of an external breast prosthesis. The patient visit commonly occurs in a durable medical equipment (DME) supplier clinic, prosthetics clinic, or outpatient breast surgery/reconstruction clinic. The clinical workflow includes: a clinician or certified mastectomy fitter documents the surgical history (side and date of mastectomy), current chest wall or reconstruction status (healed incision, presence of expanders or implants), measurements and symmetry assessment, and patient preference for silicone external prosthesis. Medical necessity is established with documentation of mastectomy, physical exam findings (such as tissue deficit or asymmetry), and rationale for silicone prosthesis. The supplier selects an appropriate L8030 prosthesis (silicone or equal, without integral adhesive), records any fitting adjustments, provides patient education on use and care, and submits the claim to the patient’s payer. Typical sites of service are outpatient prosthetics/DME supplier offices, hospital outpatient clinics, or ambulatory surgical centers when provided in conjunction with reconstructive procedures. Common payer interactions include verification of coverage and prior authorization when required by payors such as Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
LT |